全部| 求助中| 待确认 按时间排序|按积分排序

Dapagliflozin as an Adjunct to Insulin Improves Time-in-Range and Glycemic Variability versus Acarbose in Adults With Type 1 Diabetes: A Randomized Crossover Trial

用户sGjaISN0bR0M 6分钟前 10 待确认

https://doi.org/10.1063/1.3499306

用户M3BcEs4Bx3e4 23分钟前 10 待确认

Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2–3 trial

用户EO9nReo4Hj6s 24分钟前 10 已完结

On-demand transarterial chemoembolisation combined with atezolizumab and bevacizumab in patients with untreated hepatocellular carcinoma (TALENTACE): a multicentre, randomised, open-label, phase 3 trial

用户EO9nReo4Hj6s 26分钟前 10 已完结

Redox‐Neutral Vicinal Dialkylation of Aryl Boronic Esters via the Palladium/Norbornene Cooperative Catalysis

用户HSsPIR68UQeA 27分钟前 10 待确认

CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer

用户EO9nReo4Hj6s 30分钟前 10 已关闭

Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo Trial

用户EO9nReo4Hj6s 31分钟前 10 已完结

Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study

用户EO9nReo4Hj6s 32分钟前 10 已关闭

New and Practical Synthesis of N-(Pyrimidin-5-ylmethyl)pyridin-2-amine, the Key Intermediate to Triflumezopyrim

用户0-aW-smL_VcI 33分钟前 10 待确认

6PPD-Q: A comprehensive critical review on environmental occurrence, toxicological mechanisms, risk assessment, and mitigating strategies

用户BDuR-duQ4JJ4 52分钟前 10 待确认
首页 1 2 3 4 下页

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com